Michael Stewart - Perrigo Company Senior Vice President - Global Human Resources

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 35px;;'>PRG</div>
PRGO -- USA Stock  

Last Earning Anouncement Date: December 31, 2015  

  President
Mr. Michael R. Stewart is Senior Vice President Global Human Resources of the Company. He served as Vice President, Human Resources from 1993 to September 2004. Mr. Stewart began his employment with the Company in 1981.
Age: 62  President Since 2004      
353 1 709 4000  http://www.perrigo.com

Michael Stewart Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 2.19 % which means that it generated profit of $2.19 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 4.32 % meaning that it created $4.32 on every $100 dollars invested by stockholders.
The company currently holds 3.5 B in liabilities with Debt to Equity (D/E) ratio of 60.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 2.03 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Joseph LaRosaRegeneron Pharmaceuticals
2019
Alok SonigDr Reddys Laboratories Ltd
2015
Amit BiswasDr Reddys Laboratories Ltd
2016
Roman TrawickiZoetis
2015
Alejandro BernalZoetis
2015
Reshma KewalramaniVertex Pharmaceuticals Incorpor
2018
Charles WagnerVertex Pharmaceuticals Incorpor
2019
Stefan WeiskopfZoetis
2013
Daniel PlewRegeneron Pharmaceuticals
2016
Joyce LeeZoetis
2012
Catherine KnuppZoetis
2012
Charles MilsteinVertex Pharmaceuticals Incorpor
2017
Cartikeya ReddyDr Reddys Laboratories Ltd
2016
Michael AbermanRegeneron Pharmaceuticals
2015
Thomas GraneyVertex Pharmaceuticals Incorpor
2017
Samiran DasDr Reddys Laboratories Ltd
2016
Sandra BeatyZoetis
2012
Sripada ChandrasekharDr Reddys Laboratories Ltd
2013
Heidi ChenZoetis
2012
K RaoDr Reddys Laboratories Ltd
2016
Peter PowchikRegeneron Pharmaceuticals
2006

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Did you try this?

Run My Watchlist Analysis Now

   

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch Module

Currently Active Assets on Macroaxis

C   
Purchased over 30 shares of
few hours ago
Traded for 80.1
F   
Purchased over 300 shares of
few hours ago
Traded for 9.16
CRSP   
Purchased over 50 shares of
few hours ago
Traded for 58.39
GM   
Purchased over 70 shares of
few hours ago
Traded for 34.91
S   
Purchased over 500 shares of
few hours ago
Traded for 5.02
Please also check Your Equity Center. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.